$COLL
COLLEGIUM PHARMACEUTICAL, INC

2022 Q1 Form 10-Q Financial Statement

#000155837022008090 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $83.75M $87.72M
YoY Change -4.53% 14.65%
Cost Of Revenue $35.26M $32.12M
YoY Change 9.75% -14.39%
Gross Profit $48.50M $55.60M
YoY Change -12.77% 42.61%
Gross Profit Margin 57.9% 63.38%
Selling, General & Admin $54.53M $31.48M
YoY Change 73.24% 0.69%
% of Gross Profit 112.44% 56.61%
Research & Development $3.983M $2.930M
YoY Change 35.94% 9.9%
% of Gross Profit 8.21% 5.27%
Depreciation & Amortization $715.0K $439.0K
YoY Change 62.87% 121.72%
% of Gross Profit 1.47% 0.79%
Operating Expenses $58.51M $34.41M
YoY Change 70.06% 1.41%
Operating Profit -$10.02M $21.19M
YoY Change -147.26% 318.73%
Interest Expense $5.831M $5.721M
YoY Change 1.92% 18.62%
% of Operating Profit 27.0%
Other Income/Expense, Net
YoY Change
Pretax Income -$15.84M $15.47M
YoY Change -202.38% 3338.67%
Income Tax -$2.773M -$188.0K
% Of Pretax Income -1.21%
Net Earnings -$13.07M $15.66M
YoY Change -183.44% 3380.44%
Net Earnings / Revenue -15.6% 17.85%
Basic Earnings Per Share -$0.39 $0.45
Diluted Earnings Per Share -$0.39 $0.41
COMMON SHARES
Basic Shares Outstanding 33.67M 34.95M
Diluted Shares Outstanding 33.67M 41.16M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.7M $182.8M
YoY Change -41.63% 57.31%
Cash & Equivalents $106.7M $182.8M
Short-Term Investments
Other Short-Term Assets $10.45M $4.900M
YoY Change 113.24% -19.67%
Inventory $80.15M $15.50M
Prepaid Expenses
Receivables $166.3M $93.16M
Other Receivables $0.00 $0.00
Total Short-Term Assets $363.6M $296.3M
YoY Change 22.72% 32.47%
LONG-TERM ASSETS
Property, Plant & Equipment $20.20M $19.76M
YoY Change 2.24% 50.32%
Goodwill $131.5M
YoY Change
Intangibles $694.8M
YoY Change
Long-Term Investments
YoY Change
Other Assets $77.00K $129.0K
YoY Change -40.31% -22.29%
Total Long-Term Assets $882.5M $349.8M
YoY Change 152.32% -14.93%
TOTAL ASSETS
Total Short-Term Assets $363.6M $296.3M
Total Long-Term Assets $882.5M $349.8M
Total Assets $1.246B $646.1M
YoY Change 92.88% 1.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.851M $8.666M
YoY Change -55.56% 41.16%
Accrued Expenses $41.07M $16.89M
YoY Change 143.09% -10.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0M $47.70M
YoY Change 109.64% 1.71%
Total Short-Term Liabilities $373.6M $230.2M
YoY Change 62.3% -5.81%
LONG-TERM LIABILITIES
Long-Term Debt $668.6M $237.3M
YoY Change 181.74% -1.17%
Other Long-Term Liabilities $7.913M $8.600M
YoY Change -7.99% -7.53%
Total Long-Term Liabilities $676.5M $245.9M
YoY Change 175.11% -1.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $373.6M $230.2M
Total Long-Term Liabilities $676.5M $245.9M
Total Liabilities $1.050B $476.0M
YoY Change 120.59% -3.58%
SHAREHOLDERS EQUITY
Retained Earnings -$269.4M -$312.2M
YoY Change -13.7% -13.15%
Common Stock $36.00K $35.00K
YoY Change 2.86% 2.94%
Preferred Stock
YoY Change
Treasury Stock (at cost) $47.86M
YoY Change
Treasury Stock Shares $2.458M
Shareholders Equity $196.1M $170.0M
YoY Change
Total Liabilities & Shareholders Equity $1.246B $646.1M
YoY Change 92.88% 1.78%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$13.07M $15.66M
YoY Change -183.44% 3380.44%
Depreciation, Depletion And Amortization $715.0K $439.0K
YoY Change 62.87% 121.72%
Cash From Operating Activities -$25.32M $20.57M
YoY Change -223.07% -408.44%
INVESTING ACTIVITIES
Capital Expenditures $108.0K $428.0K
YoY Change -74.77% -48.8%
Acquisitions $572.1M
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$572.2M -$428.0K
YoY Change 133586.21% -99.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 517.8M -11.47M
YoY Change -4614.86% -103.55%
NET CHANGE
Cash From Operating Activities -25.32M 20.57M
Cash From Investing Activities -572.2M -428.0K
Cash From Financing Activities 517.8M -11.47M
Net Change In Cash -79.73M 8.674M
YoY Change -1019.16% -116.94%
FREE CASH FLOW
Cash From Operating Activities -$25.32M $20.57M
Capital Expenditures $108.0K $428.0K
Free Cash Flow -$25.42M $20.14M
YoY Change -226.22% -368.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2022Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2022Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2022Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001267565
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
713-3699
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-37372
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Collegium Pharmaceutical, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0416362
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
100 Technology Center Drive
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Stoughton
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02072
CY2022Q1 dei City Area Code
CityAreaCode
781
CY2022Q1 dei Trading Symbol
TradingSymbol
COLL
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33973335
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106698000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
186426000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
166345000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105844000
CY2022Q1 us-gaap Inventory Net
InventoryNet
80146000
CY2021Q4 us-gaap Inventory Net
InventoryNet
17394000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10449000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5879000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
363638000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
315543000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20202000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19491000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7812000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7644000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
694799000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
268723000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
25554000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
78042000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
77000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
87000
CY2022Q1 us-gaap Goodwill
Goodwill
131512000
CY2022Q1 us-gaap Assets
Assets
1246141000
CY2021Q4 us-gaap Assets
Assets
692077000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3851000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4189000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41068000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29214000
CY2022Q1 coll Accrued Rebates Returns And Discounts Current
AccruedRebatesReturnsAndDiscountsCurrent
227476000
CY2021Q4 coll Accrued Rebates Returns And Discounts Current
AccruedRebatesReturnsAndDiscountsCurrent
196996000
CY2022Q1 us-gaap Loans Payable Current
LoansPayableCurrent
100000000
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
48353000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1178000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
814000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
373573000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
279566000
CY2022Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
528390000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
61666000
CY2022Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
140189000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
139966000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7913000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7951000
CY2022Q1 us-gaap Liabilities
Liabilities
1050065000
CY2021Q4 us-gaap Liabilities
Liabilities
489149000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36380997
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33923148
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35806119
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33655402
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
36000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
36000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
513312000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
502095000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-269411000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-256342000
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2457849
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2150717
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
47861000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
42861000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
196076000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
202928000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1246141000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
692077000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83751000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87721000
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
16332000
CY2021Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
15328000
CY2022Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
18923000
CY2021Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
16795000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35255000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32123000
CY2022Q1 us-gaap Gross Profit
GrossProfit
48496000
CY2021Q1 us-gaap Gross Profit
GrossProfit
55598000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3983000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2930000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54528000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
31476000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
58511000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
34406000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10015000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
21192000
CY2022Q1 us-gaap Interest Expense
InterestExpense
5831000
CY2021Q1 us-gaap Interest Expense
InterestExpense
5721000
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
4000
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
3000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15842000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15474000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2773000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-188000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-13069000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
15662000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33673912
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34951740
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33673912
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41160092
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-13069000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
15662000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18923000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16795000
CY2022Q1 us-gaap Depreciation
Depreciation
715000
CY2021Q1 us-gaap Depreciation
Depreciation
439000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6038000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6135000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6879000
CY2022Q1 coll Operating Lease Payments Non Cash
OperatingLeasePaymentsNonCash
158000
CY2021Q1 coll Operating Lease Payments Non Cash
OperatingLeasePaymentsNonCash
7000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
913000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
919000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5006000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9836000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-330000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
400000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-677000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
115000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-350000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1350000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6838000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8029000
CY2022Q1 coll Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
-21865000
CY2021Q1 coll Increase Decrease In Accrued Rebates Returns And Discounts
IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts
-401000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25315000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20570000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
108000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
428000
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
572069000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-572177000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-428000
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
203000
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
358000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3261000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4182000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3382000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3508000
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
12500000
CY2022Q1 coll Proceeds From Term Note Modification
ProceedsFromTermNoteModification
517682000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
517764000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11468000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-79728000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8674000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188973000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176663000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109245000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
185337000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106698000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
182790000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2547000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
109245000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
185337000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
5833000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
5746000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2114000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
418000
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
148000
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
560000
CY2021Q1 coll Inventory Used In Construction And Installation Of Property And Equipment
InventoryUsedInConstructionAndInstallationOfPropertyAndEquipment
516000
CY2022Q1 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2022Q1 coll Returns Policy Threshold Product Return Period
ReturnsPolicyThresholdProductReturnPeriod
P18M
CY2022Q1 coll Returns Policy Threshold Product Return Period Prior To Expiration
ReturnsPolicyThresholdProductReturnPeriodPriorToExpiration
P6M
CY2022Q1 coll Returns Policy Threshold Product Return Period After Expiration
ReturnsPolicyThresholdProductReturnPeriodAfterExpiration
P12M
CY2022Q1 coll Returns Policy Threshold Product Return Period
ReturnsPolicyThresholdProductReturnPeriod
P18M
CY2021 coll Maximum Percentage Of Actual Return To Returns Claimed
MaximumPercentageOfActualReturnToReturnsClaimed
0.20
CY2021Q1 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
1165000
CY2022Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-13069000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
83751000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87721000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-13069000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
15662000
CY2021Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
16827000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33673912
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34951740
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33673912
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41160092
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2021Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2022Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2022Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
135388000
CY2022Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
140189000
CY2022Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
650000000
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
8360000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3685000
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
34907000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1007000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
36879000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12702000
CY2022Q1 us-gaap Inventory Net
InventoryNet
80146000
CY2021Q4 us-gaap Inventory Net
InventoryNet
17394000
CY2022Q1 us-gaap Goodwill
Goodwill
131512000
CY2022Q1 us-gaap Goodwill
Goodwill
131512000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
966170000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
271371000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
694799000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
521170000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
252447000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
268723000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18923000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16795000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
114228000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
152305000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
152305000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
152304000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
85124000
CY2022Q1 coll Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
38533000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
694799000
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
9000000
CY2022Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
7912000
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
9930000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4153000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3623000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3730000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
807000
CY2022Q1 coll Accrued Product Taxes And Fees Current
AccruedProductTaxesAndFeesCurrent
3102000
CY2021Q4 coll Accrued Product Taxes And Fees Current
AccruedProductTaxesAndFeesCurrent
2570000
CY2022Q1 coll Accrued Incentive Compensation Current
AccruedIncentiveCompensationCurrent
2346000
CY2021Q4 coll Accrued Incentive Compensation Current
AccruedIncentiveCompensationCurrent
851000
CY2022Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2043000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
622000
CY2022Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
1649000
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
697000
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1364000
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2634000
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
471000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1415000
CY2021Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
3222000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5298000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2843000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41068000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29214000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
202928000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3261000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
203000
CY2022Q1 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue
-3382000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6135000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-13069000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
196076000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
186031000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4102000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
358000
CY2021Q1 coll Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units And Performance Share Units Value
StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsAndPerformanceShareUnitsValue
-3508000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6879000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
15662000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
170035000
CY2021Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000
CY2021Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6135000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6879000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
47103000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2773000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-188000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.175
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.012
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2773000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-188000

Files In Submission

Name View Source Status
0001558370-22-008090-index-headers.html Edgar Link pending
0001558370-22-008090-index.html Edgar Link pending
0001558370-22-008090.txt Edgar Link pending
0001558370-22-008090-xbrl.zip Edgar Link pending
coll-20220331.xsd Edgar Link pending
coll-20220331x10q.htm Edgar Link pending
coll-20220331x10q001.jpg Edgar Link pending
coll-20220331x10q_htm.xml Edgar Link completed
coll-20220331xex10d3.htm Edgar Link pending
coll-20220331xex10d4.htm Edgar Link pending
coll-20220331xex10d5.htm Edgar Link pending
coll-20220331xex10d6.htm Edgar Link pending
coll-20220331xex10d7.htm Edgar Link pending
coll-20220331xex31d1.htm Edgar Link pending
coll-20220331xex31d2.htm Edgar Link pending
coll-20220331xex32d1.htm Edgar Link pending
coll-20220331xex32d2.htm Edgar Link pending
coll-20220331_cal.xml Edgar Link unprocessable
coll-20220331_def.xml Edgar Link unprocessable
coll-20220331_lab.xml Edgar Link unprocessable
coll-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending